The Dow Chemical Company (Dow) is engaged in the manufacture and sale of chemicals, plastic materials, agricultural and services, and other specialized products and services. It delivers a range of products and services to customers in approximately 160 countries to growth sectors such as electronics, water, energy, coatings and agriculture. The Company operated 214 manufacturing sites in 37 countries. Dow operates in eight business segments: Electronic and Specialty materials, Coatings and Infrastructure, Health and Agricultural sciences, Performance systems, Performance products, Basic plastics, Basic chemicals, and Hydrocarbons and Energy. The Company is also engaged in the property and casualty insurance and reinsurance business primarily through its Liana Limited subsidiaries. In May 2010, OMNOVA Solutions Inc. acquired The Dow Chemical Company's hollow sphere plastic pigment (HPP) product line and terminated the RohmNova paper coatings joint venture.

Research Grants 184 show all


$7.1M
2015

$1M
2016

$1.2M
2017

$256.5K
2018

$13M
2019

Patents 149,008show all

  • 13,095
    C08G - Macromolecular compounds obtained otherwise than by reactions only involving unsaturated carbon-to-carbon bonds
  • 11,601
    C08L - Compositions of macromolecular compounds
  • 10,279
    C08F - Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds
  • 10,196
    C07C - Acyclic or carbocyclic compounds
  • 6,843
    C07D - Heterocyclic compounds
  • 6,799
    C08J - Working-up
  • 6,416
    C08K - Use of inorganic or non-macromolecular organic substances as compounding ingredients
  • 5,885
    A01N - Preservation of bodies of humans or animals or plants or parts thereof
  • 4,872
    B01J - Chemical or physical processes, e.g. catalysis or colloid chemistry
  • 4,569
    B29C - Shaping or joining of plastics

Clinical Trials 1show all

1N/A

SEC Filings show all


276
8-K

72
10-Q

23
10-K

2
D

Contact Information

2030 Dow Center
Midland, MI 48674-2030
United States

Overview

Total FundingEmployeesLast Funding DateStatus
51-100Acquired

SEC Form D Funding Events

DateOfferedSoldType
2009-03-24$2,500,000,000$2,500,000,000Equity
2009-03-24$500,000,000$500,000,000Equity, Option to Acquire

Key Executives

  • William F. Banholzer
    Executive Officer
  • Carol A. Dudley
    Executive Officer
  • Gregory M. Freiwald
    Executive Officer
  • Michael R. Gambrell
    Executive Officer
  • Heinz Haller
    Executive Officer
  • Charles J. Kalil
    Executive Officer
  • David E. Kepler
    Executive Officer
  • Andrew N. Liveris
    Director, Executive Officer
  • Juan R. Luciano
    Executive Officer
  • James D. McIlvenny
    Executive Officer
  • Geoffery E. Merszei
    Director, Executive Officer
  • Fernando Ruiz
    Executive Officer
  • William H. Weideman
    Executive Officer
  • Arnold A. Allemang
    Director
  • Jacqueline K. Barton
    Director
  • James A. Bell
    Director
  • Jeff M. Fettig
    Director
  • Barbara Hackman Franklin
    Director
  • John B. Hess
    Director
  • Dennis H. Reilley
    Director
  • James M. Ringler
    Director
  • Ruth G. Shaw
    Director
  • Paul G. Stern
    Director